Differential expression of C-Reactive protein and Serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Calero, Carmen ^a,b   Arellano, Elena ^a   Lopez Villalobos, Jose L ^a   Sánchez López, Verónica ^a   Moreno Mata, Nicolás ^a   López Campos, José L ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Acute phase reactants; C reactive protein; Chronic obstructive pulmonary disease; Chronic systemic inflammatory syndrome; Serum amyloid A

Indexed keywords

C REACTIVE PROTEIN; FLUTICASONE PROPIONATE; SERUM AMYLOID A; SERUM AMYLOID A1; SERUM AMYLOID A2; SERUM AMYLOID A4; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; FORCED EXPIRATORY VOLUME; GENE EXPRESSION; HUMAN; LIVER DISEASE; LUNG ALVEOLUS CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROBLAST; LUNG PARENCHYMA; MALE; MIDDLE AGED; OBSERVATIONAL STUDY; PEPTIC ULCER; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOKING; COMPARATIVE STUDY; EPITHELIUM CELL; FIBROBLAST; GENE EXPRESSION REGULATION; GENETICS; LUNG FUNCTION TEST; MACROPHAGE; METABOLISM; NONPARAMETRIC TEST; PATHOLOGY; PROCEDURES; REAL TIME POLYMERASE CHAIN REACTION; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; EPITHELIAL CELLS; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; LOGISTIC MODELS; MACROPHAGES; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REAL-TIME POLYMERASE CHAIN REACTION; REFERENCE VALUES; RESPIRATORY FUNCTION TESTS; SERUM AMYLOID A PROTEIN; SEVERITY OF ILLNESS INDEX; SMOKING; STATISTICS, NONPARAMETRIC;

EID: 84902182471     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-95     Document Type: Article

References (39)

1. López Varela MV, Montes de Oca M, Halbert R, Muiño A, Tálamo C, Pérez-Padilla R, Jardim JR, Valdivia G, Pertuzé J, Menezes AM, . PLATINO team Comorbidities and health status in individuals with and without COPD in five latin american cities: the PLATINO study. Arch Bronconeumol 2013, 49:468-474. PLATINO team.
2. Vanfleteren LE, Spruit MA, Groenen M, Gaffron S, van Empel VP, Bruijnzeel PL, Rutten EP, Op 't Roodt J, Wouters EF, Franssen FM. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013, 187:728-735. 10.1164/rccm.201209-1665OC, 23392440.
3. Miller J, Edwards LD, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, Miller BE, Rennard S, Silverman EK, Tal-Singer R, Vestbo J, Wouters E, Yates JC, Macnee W. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med 2013, 107:1376-1384. 10.1016/j.rmed.2013.05.001, 23791463.
4. Fabbri LM, Rabe KF. From COPD to chronic systemic inflammatory syndrome?. Lancet 2007, 370:797-799. 10.1016/S0140-6736(07)61383-X, 17765529.
5. Garcia-Rio F, Miravitlles M, Soriano JB, Munoz L, Duran-Tauleria E, Sánchez G, Sobradillo V, Ancochea J, . EPI-SCAN Steering Committee Systemic inflammation in chronic obstructive pulmonary disease: a population-based study. Respir Res 2010, 11:63. 10.1186/1465-9921-11-63, 2891677, 20500811, EPI-SCAN Steering Committee.
6. Agusti A, Soriano JB. COPD as a systemic disease. COPD 2008, 5:133-138. 10.1080/15412550801941349, 18415812.
7. Gan WQ, Man SF, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004, 59:574-580. 10.1136/thx.2003.019588, 1747070, 15223864.
8. Wouters EF, Groenewegen KH, Dentener MA, Vernooy JH. Systemic inflammation in chronic obstructive pulmonary disease: the role of exacerbations. Proc Am Thorac Soc 2007, 4:626-634. 10.1513/pats.200706-071TH, 18073394.
9. Smith DJ, Yerkovich ST, Towers MA, Carroll ML, Thomas R, Upham JW. Reduced soluble receptor for advanced glycation end-products in COPD. Eur Respir J 2011, 37:516-522. 10.1183/09031936.00029310, 20595148.
10. Sunyer J, Pistelli R, Plana E, Andreani M, Baldari F, Kolz M, Koenig W, Pekkanen J, Peters A, Forastiere F. Systemic inflammation, genetic susceptibility and lung function. Eur Respir J 2008, 32:92-97. 10.1183/09031936.00052507, 18385179.
11. Sode BF, Dahl M, Nordestgaard BG. Myocardial infarction and other co-morbidities in patients with chronic obstructive pulmonary disease: a Danish nationwide study of 7.4 million individuals. Eur Heart J 2011, 32:2365-2375. 10.1093/eurheartj/ehr338, 21875856.
12. Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence. Thorax 2010, 65:930-936. 10.1136/thx.2009.130260, 20627907.
13. Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, MacCallum PK, Wedzicha JA. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest 2005, 128:1995-2004. 10.1378/chest.128.4.1995, 16236847.
14. López-Campos JL, Calero C, Rojano B, López-Porras M, Sáenz-Coronilla J, Blanco AI, Sánchez-López V, Tobar D, Montes-Worboys A, Arellano E. C-reactive protein and serum amyloid a overexpression in lung tissues of chronic obstructive pulmonary disease patients: a case-control study. Int J Med Sci 2013, 10:938-947. 10.7150/ijms.6152, 3691791, 23801879.
15. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994, 47:1245-1251. 10.1016/0895-4356(94)90129-5, 7722560.
16. León-Atance P, Moreno-Mata N, González-Aragoneses F, Cañizares-Carretero M, García-Jiménez MD, Genovés-Crespo M, Honguero-Martínez AF, Rombolá CA, Simón-Adiego CM, Peñalver-Pascual R. Multicenter analysis of survival and prognostic factors in pathologic stage I non-small-cell lung cancer according to the new 2009 TNM classification. Arch Bronconeumol 2011, 47:441-446.
17. Malle E, De Beer FC. Human serum amyloid A (SAA) protein: a prominent acute-phase reactant for clinical practice. Eur J Clin Invest 1996, 26:427-435. 10.1046/j.1365-2362.1996.159291.x, 8817153.
18. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008, 3:1101-1108. 10.1038/nprot.2008.73, 18546601.
19. de Andrade M, Li Y, Marks RS, Deschamps C, Scanlon PD, Olswold CL, Jiang R, Swensen SJ, Sun Z, Cunningham JM, Wampfler JA, Limper AH, Midthun DE, Yang P. Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila) 2012, 5:365-373. 10.1158/1940-6207.CAPR-11-0243, 3414259, 22044695.
20. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454. 10.1056/NEJM199902113400607, 9971870.
21. Gorska K, Maskey-Warzechowska M, Krenke R. Airway inflammation in chronic obstructive pulmonary disease. Curr Opin Pulm Med 2010, 16:89-96. 10.1097/MCP.0b013e3283341ba0, 19904205.
22. Rahman I, Adcock IM. Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 2006, 28:219-242. 10.1183/09031936.06.00053805, 16816350.
23. Elkington PT, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006, 61:259-266. 10.1136/thx.2005.051979, 2080735, 16227332.
24. Henson PM, Cosgrove GP, Vandivier RW. State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006, 3:512-516. 10.1513/pats.200603-072MS, 2647642, 16921132.
25. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, Ciaccia A, Fabbri LM. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 1993, 147:301-306. 10.1164/ajrccm/147.2.301, 8430952.
26. Auerbach O, Stout AP, Hammond EC, Garfinkel L. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N Engl J Med 1961, 265:253-267. 10.1056/NEJM196108102650601, 13685078.
27. Górska K, Krenke R, Kosciuch J, Korczynski P, Zukowska M, Domagala-Kulawik J, Maskey-Warzechowska M, Chazan R. Relationship between airway inflammation and remodeling in patients with asthma and chronic obstructive pulmonary disease. Eur J Med Res 2009, 14(Suppl 4):90-96.
28. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH. Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease. Respir Res 2011, 12:130. 10.1186/1465-9921-12-130, 3198934, 21970519.
29. Wang Q, Wang Y, Zhang Y, Zhang Y, Xiao W. The role of uPAR in epithelial-mesenchymal transition in small airway epithelium of patients with chronic obstructive pulmonary disease. Respir Res 2013, 14:67. 10.1186/1465-9921-14-67, 3700841, 23806081.
30. Sohal SS, Reid D, Soltani A, Ward C, Weston S, Muller HK, Wood-Baker R, Walters EH. Reticular basement membrane fragmentation and potential epithelial mesenchymal transition is exaggerated in the airways of smokers with chronic obstructive pulmonary disease. Respirology 2010, 15:930-938. 10.1111/j.1440-1843.2010.01808.x, 20630030.
31. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Paré PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004, 350:2645-2653. 10.1056/NEJMoa032158, 15215480.
32. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, Mueller KC, Branscheid D, Welker L, Watz H, Magnussen H, Rennard SI. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 2008, 178:248-260. 10.1164/rccm.200706-929OC, 2542423, 18467512.
33. Spurzem JR, Rennard SI. Pathogenesis of COPD. Semin Respir Crit Care Med 2005, 26:142-153. 10.1055/s-2005-869535, 16088433.
34. Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012, 186:982-988. 10.1164/rccm.201206-1113OC, 22983959.
35. Gaki E, Kontogianni K, Papaioannou AI, Bakakos P, Gourgoulianis KI, Kostikas K, Alchanatis M, Papiris S, Loukides S. Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD 2011, 8:408-413. 10.3109/15412555.2011.619599, 22149400.
36. Hillas G, Loukides S, Kostikas K, Bakakos P. Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?. Curr Med Chem 2009, 16:2824-2838. 10.2174/092986709788803178, 19689266.
37. Vernooy JH, Küçükaycan M, Jacobs JA, Chavannes NH, Buurman WA, Dentener MA, Wouters EF. Local and systemic inflammation in patients with chronic obstructive pulmonary disease: soluble tumor necrosis factor receptors are increased in sputum. Am J Respir Crit Care Med 2002, 166:1218-1224. 10.1164/rccm.2202023, 12403691.
38. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, Mueller R, Nolan T, Pfaffl MW, Shipley GL, Vandesompele J, Wittwer CT. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009, 55:611-622. 10.1373/clinchem.2008.112797, 19246619.
39. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999, 19:1720-1730. 83965, 10022859.